Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05921552 · ClinicalTrials.gov registry record · NA

Senior Adult Hepatobiliary Prehab Study

A NA study of Cholangiocarcinoma and Liver Metastases, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Active
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT05921552 is a NA study of Cholangiocarcinoma and Liver Metastases that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 25 participants, below the 385-participant average among 60 other Cholangiocarcinoma trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05921552, a NA study of Cholangiocarcinoma and Liver Metastases, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to evaluate an exercise program for individuals with hepatobiliary cancer planning for surgery.

Interventions

  • BEHAVIORAL Resistance Training
  • BEHAVIORAL Aerobic Training

Study Locations (1)

Florida

  • Moffitt Cancer Center - Tampa

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2023-06-26
Est. Completion 2026-11-19
Phase NA

What the Registry Record Tells You About NCT05921552

The ClinicalTrials.gov registry entry for NCT05921552 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 385-participant average among 60 other Cholangiocarcinoma trials with a reported enrollment target (94% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cholangiocarcinoma appearing as the primary indexed condition, and to 2 interventions - of which Resistance Training is the first listed.

NCT05921552 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05921552 about?

NCT05921552 is a clinical study titled "Senior Adult Hepatobiliary Prehab Study". The purpose of the study is to evaluate an exercise program for individuals with hepatobiliary cancer planning for surgery.

What is the current status of trial NCT05921552?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2023-06-26. Estimated completion is 2026-11-19.

What conditions does trial NCT05921552 study?

This clinical trial studies the following conditions: Cholangiocarcinoma, Liver Metastases, Hepatobiliary Cancer.

What interventions are being tested in trial NCT05921552?

The interventions under investigation include: Resistance Training (BEHAVIORAL), Aerobic Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05921552?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05921552 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cholangiocarcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.